2025
SJR Q1
JCR Q2 · 1,5
1 eşleşen makale
SCIE
Dergi ayrıntısı
Pharmaceutical Statistics
- Yayıncı
- John Wiley and Sons Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1539160415391612
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,986
- Quartile Q1
- H-Index 53
- Atıf/yayın 1,92
- Doküman (3y) 244
- Atıf (3y) 439
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 1,5
- 5Y JIF 1,9
- JCI 0,52
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Pharmacology Q2
- Pharmacology (medical) Q1
- Statistics and Probability Q1
Alanlar
- Mathematics
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Pharmacology & Pharmacy | Statistics & Probability
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,986 | 1,5 | 1,9 | 0,52 | Q3 | 53 |
| 2024 | Q1 | Q2 | 1,074 | 1,4 | 1,6 | 0,54 | Q3 | 49 |
| 2023 | Q1 | Q2 | 1,074 | 1,3 | 1,5 | 0,54 | Q2 | 49 |
| 2022 | Q2 | Q2 | 0,832 | 1,5 | 1,6 | 0,51 | Q3 | 49 |
| 2021 | Q2 | Q3 | 0,775 | 1,2 | 1,6 | 0,49 | Q3 | 49 |
| 2020 | Q1 | Q2 | 1,421 | 1,9 | 2,1 | 0,68 | Q2 | 49 |
| 2019 | Q1 | Q2 | 1,223 | 1,4 | 1,4 | 0,65 | Q2 | 49 |
| 2018 | — | Q2 | — | 1,6 | 1,4 | 0,63 | Q2 | — |
| 2017 | Q1 | Q3 | 1,494 | 0,9 | 1,2 | 0,59 | Q2 | 49 |
| 2016 | Q2 | Q2 | 1,004 | 1,3 | 1,8 | — | — | 49 |
| 2015 | Q1 | Q2 | 1,18 | 1,2 | 1,6 | — | — | 49 |
| 2014 | Q1 | Q3 | 1,276 | 0,8 | 1,4 | — | — | 49 |
| 2013 | Q1 | Q2 | 0,976 | 1,1 | 1,3 | — | — | 49 |
| 2012 | Q2 | Q2 | 0,76 | 1 | 1,3 | — | — | 49 |
| 2011 | Q2 | Q1 | 0,906 | 2,1 | 2,2 | — | — | 49 |
| 2010 | Q1 | Q1 | 1,25 | 1,6 | 1,5 | — | — | 49 |
| 2009 | — | Q1 | — | 2 | 1,4 | — | — | — |
| 2008 | — | Q1 | — | 1,7 | 1,2 | — | — | — |
| 2007 | — | Q3 | — | 0,8 | — | — | — | — |
| 2006 | — | Q2 | — | 0,9 | — | — | — | — |
| 2005 | — | Q3 | — | 0,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 286/356 |
| 2025 | STATISTICS & PROBABILITY | SCIE | Q2 | Q3 | 69/170 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 280/352 |
| 2024 | STATISTICS & PROBABILITY | SCIE | Q2 | Q3 | 61/169 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 283/354 |
| 2023 | STATISTICS & PROBABILITY | SCIE | Q2 | Q2 | 65/168 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 250/278 |
| 2022 | STATISTICS & PROBABILITY | SCIE | Q2 | Q3 | 58/125 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 258/279 |
| 2021 | STATISTICS & PROBABILITY | SCIE | Q3 | Q3 | 83/125 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q2 | 229/276 |
| 2020 | STATISTICS & PROBABILITY | SCIE | Q2 | Q2 | 49/125 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 236/271 |
| 2019 | STATISTICS & PROBABILITY | SCIE | Q2 | Q2 | 52/124 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 212/267 |
| 2018 | STATISTICS & PROBABILITY | SCIE | Q2 | Q2 | 40/123 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 234/261 |
| 2017 | STATISTICS & PROBABILITY | SCIE | Q3 | Q2 | 66/123 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 210/257 |
| 2016 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 46/124 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 209/255 |
| 2015 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 45/123 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 223/255 |
| 2014 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 65/122 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 201/256 |
| 2013 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 45/119 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 206/261 |
| 2012 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 50/117 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 139/261 |
| 2011 | STATISTICS & PROBABILITY | SCIE | Q1 | — | 10/116 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 167/252 |
| 2010 | STATISTICS & PROBABILITY | SCIE | Q1 | — | 23/110 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 142/237 |
| 2009 | STATISTICS & PROBABILITY | SCIE | Q1 | — | 16/100 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/219 |
| 2008 | STATISTICS & PROBABILITY | SCIE | Q1 | — | 17/92 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 177/205 |
| 2007 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 47/91 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 165/199 |
| 2006 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 37/83 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 168/193 |
| 2005 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 41/81 |